Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer
Clinical trial NCT01313390 · TERMINATED
Trial details
- NCT number
- NCT01313390
- Sponsor
- University College, London
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2011-04-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.